Neurocrine Biosciences Inc (NBIX)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 570,500 | 250,900 | 249,000 | 102,500 | 163,000 |
| Revenue | US$ in thousands | 2,355,100 | 1,883,200 | 1,411,600 | 1,107,700 | 994,700 |
| Operating profit margin | 24.22% | 13.32% | 17.64% | 9.25% | 16.39% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $570,500K ÷ $2,355,100K
= 24.22%
The operating profit margin of Neurocrine Biosciences Inc has shown some fluctuations over the past five years. In December 31, 2020, the operating profit margin was 16.39%, which decreased to 9.25% by December 31, 2021. However, the margin improved in the following years, reaching 17.64% in December 31, 2022, and 24.22% by December 31, 2024. In December 31, 2023, the operating profit margin was 13.32%.
Overall, the trend indicates variability in the company's ability to generate profits from its core operations. The recent increase in the operating profit margin suggests improvements in operational efficiency and cost management, which have positively impacted the company's profitability. It is essential for Neurocrine Biosciences Inc to maintain or further improve its operating profit margin to ensure sustainable growth and financial stability in the future.
Peer comparison
Dec 31, 2024